Richard Hughes IV

FDA Approves Moderna’s First mRNA Seasonal Flu Vaccine mFlusiva

The U.S. Food and Drug Administration has approved Moderna Inc.’s seasonal influenza vaccine mFlusiva for adults aged 50 and older,…

Read More »